Intrinsiqs

Is Haemonetics Corporation overvalued?

Haemonetics Corporation (HAE) looks fairly valued — trading about 7% below its fair value.

Fairly valued
Current price $122.94 Fair value $131.01
Price
$122.94
Fair value
$131.01
Current P/E
24.7
Normal P/E
26.4
Market cap
$5.60B
Dividend yield
0.0%
Return on equity
12.1%
Sector
Healthcare

See the full interactive analysis →

Fair value compares HAE's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.RHHBY Roche Holding AGUNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.